INmune Bio Inc Working Capital to Net Assets Ratio

Latest as of June 2026: 88.0%

INmune Bio Inc working capital to net assets ratio. INmune Bio Inc (INMB) has a Working Capital to Net Assets ratio of 88.0% as of June 2026. Working capital of $17.91 Million (current assets of $23.80 Million minus current liabilities of $5.89 Million) is measured against net assets of $20.36 Million. A higher ratio indicates strong short-term liquidity financed by the equity base. Check tangible equity quality of INmune Bio Inc to evaluate the tangible quality of the company's equity base.

WC/NA Ratio

88.0%
Working Capital / Net Assets

Working Capital

$17.91 Million
USD

Current Assets

$23.80 Million
USD

Current Liabilities

$5.89 Million
USD

Working Capital to Net Assets Ratio of INmune Bio Inc (2015–2025)

Working capital to net assets ratio of INmune Bio Inc from 2015 to 2025. This chart shows how INmune Bio Inc's Working Capital to Net Assets ratio has evolved across 11 annual periods from 2015 to 2025. As of June 2026, the ratio stands at 88.0%, reflecting working capital of $17.91 Million against net assets of $20.36 Million USD. See INmune Bio Inc defensive interval ratio to measure how many days the company can operate on defensive assets alone.

INmune Bio Inc Working Capital to Net Assets Ratio by Year (2015–2025)

INmune Bio Inc working capital to net assets ratio by year from 2015 to 2025. The table below presents the year-by-year Working Capital to Net Assets ratio for INmune Bio Inc from 2015 to 2025, covering 11 annual filings. Each row shows current assets, current liabilities, working capital, net assets, the ratio, and the change in percentage points compared to the prior year. For the complete balance sheet picture, see INmune Bio Inc asset portfolio.

Year WC/NA Ratio Working Capital (USD) Net Assets Current Assets Current Liabilities Change (pp)
2025 91.3% $21.47 Million $23.52 Million $29.89 Million $8.42 Million ▲ +43.2 pp
2024 48.1% $15.44 Million $32.10 Million $22.66 Million $7.22 Million ▼ -8.2 pp
2023 56.3% $21.48 Million $38.14 Million $39.94 Million $18.46 Million ▼ -33.1 pp
2022 89.4% $53.76 Million $60.10 Million $64.67 Million $10.92 Million ▼ -8.1 pp
2021 97.5% $78.25 Million $80.22 Million $82.61 Million $4.36 Million ▲ +40.2 pp
2020 57.3% $22.21 Million $38.75 Million $23.99 Million $1.78 Million ▲ +27.4 pp
2019 29.9% $7.06 Million $23.61 Million $7.76 Million $700.38K ▲ +29.8 pp
2018 0.2% $25.58K $16.54 Million $849.34K $823.77K ▼ -8.6 pp
2017 8.8% $1.59 Million $18.10 Million $1.90 Million $309.72K ▼ -91.2 pp
2016 100.0% $-149.20K $-149.20K $451.61K $600.81K ▲ +0.0 pp
2015 100.0% $-18.87K $-18.87K $11.88K $30.75K —
pp = percentage points